About BiosLab
BiosLab is a company based in India. The company has 57 employees as of March 31, 2024. BiosLab offers products and services including BIOTENLY ® Teneligliptin and TELEXA ® Telmisartan.
- Headquarter India
- Employees 57 as on 31 Mar, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
- Legal Name Bios Lab Pvt. Ltd
- Jurisdiction Rajkot, Gujarat, India
-
Annual Revenue
$1.38 M (USD)18.34as on Mar 31, 2023
-
Net Profit
$43.41 K (USD)26.02as on Mar 31, 2023
-
EBITDA
$136.59 K (USD)11.65as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
57
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BiosLab
BiosLab offers a comprehensive portfolio of products and services, including BIOTENLY ® Teneligliptin and TELEXA ® Telmisartan.
This product is developed for diabetes management and is manufactured under strict quality controls to ensure effective pharmacological action.
This product is formulated for hypertension treatment and is produced with advanced facilities to guarantee optimal quality and efficacy.
Funding Insights of BiosLab
Detailed funding history for BiosLab
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BiosLab
Investment portfolio details for BiosLab
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BiosLab
Detailed financials for BiosLab
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bioslab Comparisons
Peer comparison for BiosLab
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BiosLab
Detailed competitors of BiosLab
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bioslab
Complete news archive for BiosLab
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BiosLab
BiosLab is headquartered in India.
As of Mar 31, 2024, the latest employee count at BiosLab is 57.
Annual revenue of BiosLab is $1.38M as on Mar 31, 2023.
BiosLab was established in 2008 and has grown from offering two products to more than 100 world-class healthcare items. Products are manufactured with state-of-the-art facilities and undergo rigorous analytical procedures at every stage to ensure high quality and desired pharmacological effects. The company is committed to producing economically viable pharmaceuticals for all societal segments and innovating solutions for challenging ailments. Research and development efforts are prioritized to maintain dedication to global benchmarks in the pharmaceutical field, while expanding horizons through perseverance and discipline.
BiosLab offers BIOTENLY ® Teneligliptin and TELEXA ® Telmisartan.